Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 16, 2024

Safety and Efficacy of Half-Dose and Half-Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

American Journal of Ophthalmology

 

Additional Info

American Journal of Ophthalmology
Safety and Efficacy of Half-dose and Half-fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Systematic Review and Meta-analysis
Am J Ophthalmol 2024 Nov 25;[EPub Ahead of Print], M Zaman, A Mihalache, RS Huang, N Shah, MM Popovic, PJ Kertes, RH Muni, RP Kohly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading